CD19 and leukemia: We also extracted 34 genes contained in these eight selected TMERSs with differential abundance in both tumor versus normal and high versus low TMERSscore, most of which were reported to be independent prognostic factors for LUAD (e.g., CCNB1, RRM2) or excellent therapeutic targets for leukemia and some autoimmune diseases (e.g., CD19, MS4A1).